{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:06:07Z","timestamp":1782399967641,"version":"3.54.5"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164196","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T17:39:59Z","timestamp":1476812399000},"page":"e0164196","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis"],"prefix":"10.1371","volume":"11","author":[{"given":"Izabella","family":"Surowiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"\u00c4rlestig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Trygg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","article-title":"Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis","volume":"2","author":"L Klareskog","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.39603","article-title":"Review: Preclinical Rheumatoid Arthritis: Progress Toward Prevention","volume":"68","author":"K Mankia","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum-Us"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis\u2014A study of serial measurements in blood donors","volume":"50","author":"MMJ Nielen","year":"2004","journal-title":"Arthritis Rheum-Us"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-Regulation of Cytokines and Chemokines Predates the Onset of Rheumatoid Arthritis","volume":"62","author":"H Kokkonen","year":"2010","journal-title":"Arthritis Rheum-Us"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis","volume":"66","author":"VP van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2005.040659","article-title":"Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis","volume":"65","author":"MM Nielen","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.clinbiochem.2005.06.006","article-title":"The phosphatidylcholine\/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: Investigations by P-31 NMR and MALDI-TOF MS","volume":"38","author":"B Fuchs","year":"2005","journal-title":"Clin Biochem"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","article-title":"Global Metabolite Profiling of Synovial Fluid for the Specific Diagnosis of Rheumatoid Arthritis from Other Inflammatory Arthritis","volume":"9","author":"S Kim","year":"2014","journal-title":"PloS One"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.38021","article-title":"The Impact of Inflammation on Metabolomic Profiles in Patients With Arthritis","volume":"65","author":"SP Young","year":"2013","journal-title":"Arthritis Rheum-Us"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1021\/pr1002774","article-title":"1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients","volume":"9","author":"MB Lauridsen","year":"2010","journal-title":"J Proteom Res"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar3243","article-title":"Diagnostic properties of metabolic perturbations in rheumatoid arthritis","volume":"13","author":"RK Madsen","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1021\/pr300296v","article-title":"Metabolic responses to change in disease activity during tumor necrosis factor inhibition in patients with rheumatoid arthritis","volume":"11","author":"R Madsen","year":"2012","journal-title":"J Proteom Res"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/art.37921","article-title":"Metabolic profiling predicts response to anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis","volume":"65","author":"SR Kapoor","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cem.695","article-title":"Orthogonal projections to latent structures (O-PLS)","volume":"16","author":"J Trygg","year":"2002","journal-title":"J Chemometr"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00031305.1983.10483087","article-title":"A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation","volume":"37","author":"B Efron","year":"1983","journal-title":"Am Stat"},{"key":"ref18","article-title":"Signal detection theory and ROC analysis","author":"JP Egan","year":"1975"},{"issue":"23","key":"ref19","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00018-006-6155-y","article-title":"New developments in the biological functions of lysophospholipids","volume":"63","author":"E Birgbauer","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.pharmtox.41.1.507","article-title":"Lysophospholipid receptors","volume":"41","author":"N Fukushima","year":"2001","journal-title":"Annu Rev Pharmacol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nm989","article-title":"Therapeutic effects of lysophosphatidylcholine in experimental sepsis","volume":"10","author":"JJ Yan","year":"2004","journal-title":"Nat Med"},{"issue":"3\u20134","key":"ref22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2009.04.007","article-title":"G2A and LPC: Regulatory functions in immunity","volume":"89","author":"JH Kabarowski","year":"2009","journal-title":"Prostag Oth Lipid M"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2008.04.001","article-title":"Lysophospholipid acyltransferases: Novel potential regulators of the inflammatory response and target for new drug discovery","volume":"119","author":"SK Jackson","year":"2008","journal-title":"Pharmacol Therapeut"},{"issue":"5548","key":"ref24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1126\/science.1065323","article-title":"Lysophospholipids\u2014Receptor revelations","volume":"294","author":"T Hla","year":"2001","journal-title":"Science"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmed.2005.12.001","article-title":"Emerging medicinal roles for lysophospholipid signaling","volume":"12","author":"SE Gardell","year":"2006","journal-title":"Trends Mol Med"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bbamem.2006.09.026","article-title":"Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism","volume":"1768","author":"DM Zu Heringdorf","year":"2007","journal-title":"Bba-Biomembranes"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1134\/S0006297907020010","article-title":"Lysophospholipid receptors in cell signaling","volume":"72","author":"TI Torkhovskaya","year":"2007","journal-title":"Biochemistry-Moscow"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1568005310303010023","article-title":"Unfolding the pathophysiological role of bioactive lysophospholipids","volume":"3","author":"Y Xu","year":"2003","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"issue":"6801","key":"ref29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"AJ Lusis","year":"2000","journal-title":"Nature"},{"issue":"1\u20132","key":"ref30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-006-9280-x","article-title":"Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells","volume":"295","author":"N Aiyar","year":"2007","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"ref31","first-page":"RA5","article-title":"Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis","volume":"12","author":"P Kougias","year":"2006","journal-title":"Med Sci Monit"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chemphyslip.2014.07.001","article-title":"A fast method for the determination of the PC\/LPC ratio in intact serum by MALDI-TOF MS: an easy-to-follow lipid biomarker of inflammation","volume":"183","author":"R Angelini","year":"2014","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"G Schmitz","year":"2010","journal-title":"Atherosclerosis"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","article-title":"Cardiovascular comorbidity in rheumatic diseases","volume":"11","author":"MT Nurmohamed","year":"2015","journal-title":"Nature Rev Rheumatol"},{"issue":"1\u20132","key":"ref35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"K Schrocksnadel","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the immune response","volume":"81","author":"JR Moffett","year":"2003","journal-title":"Immunol. Cell Biol"},{"issue":"Suppl 1","key":"ref37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/IJTR.S11737","article-title":"Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis","volume":"6","author":"RO Williams","year":"2013","journal-title":"IJTR"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","article-title":"Autoimmune inflammation from the Th17 perspective","volume":"6","author":"J Furuzawa-Carballeda","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2205","article-title":"Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice","volume":"9","author":"S Szanto","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/art.24446","article-title":"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 cells in the joint in collagen-induced arthritis","volume":"60","author":"G Criado","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10067-005-0056-6","article-title":"Tryptophan degradation increases with stage in patients with rheumatoid arthritis","volume":"25","author":"K Schroecksnadel","year":"2006","journal-title":"Clin Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4615-0135-0_32","article-title":"Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment","volume":"527","author":"CM Forrest","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"ref43","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis","volume":"30","author":"K Schroecksnadel","year":"2003","journal-title":"J Rheumatol"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbadis.2014.05.022","article-title":"Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme","volume":"1842","author":"MG Battelli","year":"2014","journal-title":"Bba-Mol Basis Dis"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/PL00011172","article-title":"Oxidant\/antioxidant status of the erythrocytes from patients with rheumatoid arthritis","volume":"19","author":"MYB Cimen","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00914193","article-title":"Elevated Levels of Xanthine-Oxidase in Serum of Patients with Inflammatory and Autoimmune Rheumatic Diseases","volume":"17","author":"R Miesel","year":"1993","journal-title":"Inflammation"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1203\/00006450-197504000-00002","article-title":"Hypoxanthine as a measurement of hypoxia","volume":"9","author":"OD Saugstad","year":"1975","journal-title":"Pediatric Res"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/ard.50.10.669","article-title":"Hypoxanthine, xanthine, and urate in synovial fluid from patients with inflammatory arthritides","volume":"50","author":"B Gudbjornsson","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2008.04.029","article-title":"Fatty acids as modulators of the cellular production of reactive oxygen species","volume":"45","author":"P Schonfeld","year":"2008","journal-title":"Free Radical Bio Med"},{"issue":"7432","key":"ref50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"LAJ O'Neill","year":"2013","journal-title":"Nature"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B","article-title":"Chylomicron metabolism is markedly altered in systemic lupus erythematosus","volume":"43","author":"EF Borba","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:59:50Z","timestamp":1718845190000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164196"}},"subtitle":[],"editor":[{"given":"Graham R.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164196","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}